XOMA Royalty (XOMA) Income towards Parent Company (2011 - 2026)

XOMA Royalty's (XOMA) quarterly Income towards Parent Company came in at $4.5 million in Q1 2026, up 88.64% year-on-year from $2.4 million in Q1 2025, and up 117.22% quarter-over-quarter from -$25.9 million in Q4 2025.

XOMA Royalty (XOMA) Income towards Parent Company (2011 - 2026) Analysis & Trends

XOMA Royalty has disclosed Income towards Parent Company across 16 years of filings, most recently posting $4.5 million for Q1 2026.

  • Income towards Parent Company for Q1 2026 came in at $4.5 million, up 88.64% year-over-year; the trailing twelve-month figure through Mar 2026 was -$6.0 million (up 67.45% YoY), and the FY2025 annual result was -$320000.0, down 105.72% from the prior year.
  • Income towards Parent Company came in at $4.5 million for Q1 2026 at XOMA Royalty, up from -$25.9 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $14.1 million in Q3 2025 to a low of -$25.9 million in Q4 2025.
  • The 5-year median for Income towards Parent Company is -$5.8 million (2023), against an average of -$5.6 million.
  • Across the five-year window, Income towards Parent Company plunged 392.49% in 2023 and jumped 181.49% in 2025, its largest moves.
  • XOMA Royalty's Income towards Parent Company stood at -$6.2 million in 2022, then slumped by 221.0% to -$19.9 million in 2023, then jumped by 149.09% to $9.8 million in 2024, then slumped by 364.99% to -$25.9 million in 2025, then surged by 117.22% to $4.5 million in 2026.
  • The last three Income towards Parent Company figures came in at $4.5 million (Q1 2026), -$25.9 million (Q4 2025), and $14.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn -
7 Psyence Biomedical 227.32 Bn 227.31 Bn -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn
9 Abivax 91.71 Bn 91.71 Bn -
10 XOMA Royalty 5.48 Mn -60.60 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 4.47 Mn
Dec 31, 2025 -25.93 Mn
Sep 30, 2025 14.05 Mn
Jun 30, 2025 1.37 Mn
Mar 31, 2025 2.37 Mn
Dec 31, 2024 9.79 Mn
Sep 30, 2024 -17.24 Mn
Jun 30, 2024 -13.48 Mn
Mar 31, 2024 -10.56 Mn
Dec 31, 2023 -19.93 Mn
Sep 30, 2023 -5.79 Mn
Jun 30, 2023 -5.96 Mn
Mar 31, 2023 -10.17 Mn
Dec 31, 2022 -6.21 Mn
Sep 30, 2022 -4.37 Mn
Jun 30, 2022 -4.77 Mn
Mar 31, 2022 -2.07 Mn
Dec 31, 2021 29.86 Mn
Sep 30, 2021 -4.44 Mn
Jun 30, 2021 -2.24 Mn